Munsaka MS - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Correction to: Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial Experience.

Marcinak JF, Munsaka MS, Watkins PB, Ohira T, Smith N. Marcinak JF, et al. Among authors: munsaka ms. Drug Saf. 2018 Dec;41(12):1431-1437. doi: 10.1007/s40264-018-0745-0. Drug Saf. 2018. PMID: 30328587

Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial Experience.

Marcinak JF, Munsaka MS, Watkins PB, Ohira T, Smith N. Marcinak JF, et al. Among authors: munsaka ms. Drug Saf. 2018 Jun;41(6):625-640. doi: 10.1007/s40264-018-0642-6. Drug Saf. 2018. PMID: 29492878 Clinical Trial.

Criteria to assess in vivo performance and bioequivalence of generic controlled-release formulations of carbamazepine.

Bialer M, Yacobi A, Moros D, Levitt B, Houle JM, Munsaka MS. Bialer M, et al. Among authors: munsaka ms. Epilepsia. 1998 May;39(5):513-9. doi: 10.1111/j.1528-1157.1998.tb01414.x. Epilepsia. 1998. PMID: 9596204 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters